- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry.
October 8, 2020
Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including its Variant Morphologies.
October 8, 2020
Targeting the HIF2-VEGF axis in renal cell carcinoma.
October 8, 2020
From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer.
October 7, 2020
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
October 7, 2020
TiNivo: Safety and Efficacy of Tivozanib-Nivolumab Combination Therapy in Patients with Metastatic Renal Cell Carcinoma.
October 6, 2020
The Role of Metabolic Factors in Renal Cancers.
October 6, 2020
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment.
October 5, 2020
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
October 5, 2020
Nephrometry Scores: a validation of three systems for peri-operative outcomes in retroperitoneal robotic partial nephrectomy.
October 2, 2020
Urinary Human Kidney Injury Molecule-1 (hKIM-1) Is Not Increased in Patients with Renal Cell Carcinoma.
October 2, 2020
Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation.
October 1, 2020
Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis.
October 1, 2020